Wedbush reiterates Outperform on Jade Biosciences, $47 price target
Wedbush reiterated their Outperform rating on Jade Biosciences's stock with a price target of $47.00, implying an upside of 234.5% from the Sep 30 close of $14.05.
Wedbush reiterated their Outperform rating on Jade Biosciences's stock with a price target of $47.00, implying an upside of 234.5% from the Sep 30 close of $14.05.